Found 111 matching trials
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. PHASE3 Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Show More Learn More & Join Trial
Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke PHASE3 Along with the current clinical trial, the efficacy and safety of 180 mg lo...
Show More Location
Kafr Elsheikh University Hospital
Learn More & Join Trial
Ticagrelor Pharmacokinetics in NSTEMI N/A Patients with myocardial infarction, which does not include all layers of t...
Show More Learn More & Join Trial
Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI PHASE4 Platelets and thrombus formation play a key role in the pathogenesis of acu...
Show More Location
Attikon University Hospital
Learn More & Join Trial
Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI PHASE4 Clopidogrel is the P2Y12 inhibitor of choice in PCI patients requiring OAC....
Show More Location
University of Florida
Learn More & Join Trial
COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS PHASE4 Ticagrelor, a new P2Y12 receptor antagonist, achieve faster, consistent and...
Show More Location
Shenyang Northern Hospital
Learn More & Join Trial
The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin PHASE4 Heart attacks are usually caused by clots in a coronary artery, depriving t...
Show More Location
Sheffield Teaching Hospitals NHS Foundation Trust
Learn More & Join Trial
Ticagrelor Therapy for RefrACTORy Migraine Study PHASE4 This is a prospective, open-label, single-arm pilot study treating 40 subje...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor N/A The aim of this study is to compare circadian variability of antiplatelet e...
Show More Location
Department of Cardiology, Dr. A. Jurasz University Hospital, Collegium Medicum, Nicolaus Copernicus University
Learn More & Join Trial
The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man PHASE2 Background: Coronary heart disease is the most common cause of death in ind...
Show More Location
Medical University of Vienna
Learn More & Join Trial